Physician
Family Medicine
Dr. Timothy A. McAfee, MD
|
|
Give Review
Timothy McAfee works in the field of Family Medicine. He researched medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a one of the best medicals schools. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. Dr. Timothy A. McAfee is also published. He has 61 publications published. The lastest publication: "Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.'
Publications
- Quitline Cessation Counseling for Young Adult Smokers: A Randomized Clinical Trial.
- Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.
- Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation.
- Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
- Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective.
- Depressed mood and smoking experimentation among preteens.
- Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.
- HIV prevention in primary care: impact of a clinical intervention.
- Enhancing primary care HIV prevention: a comprehensive clinical intervention.
- Primary and secondary prevention services in clinical practice. Twenty years' experience in development, implementation, and evaluation.
- A review of clinical prevention services at group health cooperative of Puget Sound.
- Designing tobacco control systems and cessation benefits in managed care: skill building workshop.
- Managed care and the state tobacco settlements.
- Improving community-based prevention by transforming managed care organizations into health improvement organizations.
- Addressing a neglected coronary heart disease risk factor in an HMO: exercise counseling and fitness testing at group health cooperative.
- Telephone smoking cessation intervention: the free and clear program.
- Awakening the sleeping giant: mainstreaming efforts to decrease tobacco use in an HMO.
- Waking the health plan giant: Group Health Cooperative stops counting sheep and starts counting key tobacco indicators.
- Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization.
- The role of tobacco intervention in population-based health care: a case study.
- Sustained-release bupropion for smoking cessation.
- Transdermal nicotine: clarifications, side effects, and funding.
- How to safely draw blood from a vascular access device.
- The Tobacco Institute: helping youth say "yes" to tobacco.
- Bed sharing is not a "consumer product".
- The uninsured and Medicaid Oregon tobacco user experience in a real world, phone based cessation programme.
- Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.
- Quitlines a tool for research and dissemination of evidence-based cessation practices.
- Fax referrals, academic detailing, and tobacco quitline use: a randomized trial.
- Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation.
- Behavioral counseling and varenicline treatment for smoking cessation.
- The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline.
- Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks.
- Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline.
- The feasibility of connecting physician offices to a state-level tobacco quit line.
- Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting.
- Effectiveness of telephone support in increasing physical activity levels in primary care patients.
- Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
- Capturing tobacco status using an automated billing system: steps toward a tobacco registry.
- Heterogeneity in 12-month outcome among female and male smokers.
- Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
- A randomized trial of a family-based smoking prevention intervention in managed care.
- Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial.
- Preventing premature death: tobacco treatment services for employees.
- Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.
- Prevalence and characteristics of smokers at 30 Pacific Northwest colleges and universities.
- Provider feedback to improve 5A''s tobacco cessation in primary care: a cluster randomized clinical trial.
- Access to nicotine replacement therapy as part of a statewide tobacco telephone helpline.
- Preteen attitudes about smoking and parental factors associated with favorable attitudes.
- Physician tobacco advice to preteens in a smoking-prevention randomized trial: steering clear.
- Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation.
- Cost effectiveness of the Oregon quitline "free patch initiative".
- The impact of a free nicotine patch starter kit on quit rates in a state quit line.
- Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial.
- Phone and web-based tobacco cessation treatment: real-world utilization patterns and outcomes for 11,000 tobacco users.
- Smoking outcome by psychiatric history after behavioral and varenicline treatment.
- Promoting primary care smoking-cessation support with quitlines: the QuitLink Randomized Controlled Trial.
- Creating a perfect storm to increase consumer demand for Wisconsin''s Tobacco Quitline.
- Using free patches to improve reach of the Oregon Quit Line.
- Adherence to varenicline in the COMPASS smoking cessation intervention trial.
Schools
University of California At San Francisco
Grp Health
University of Washington
Doctors Specialties
- Family Medicine
Accepted Insurances
Education
-
University of California San Francisco School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Bruce B. Gardner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Quynh T. Bui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher B. Behrens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey P. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory Parada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debbie K. Brunner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crystal G. Kong-Wong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Perez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen C. James, MD |
|
|
Dr. Gregory J. Allen, MD |
|
|
Dr. Marc A. Houser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara J. Arnold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamie M. Phifer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arden L. Snyder, PHD |
|
|
Dr. Mindy L. Blaski, MD
This Doctor is OpenDoctor Recommended.
|